nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bone resorption marker as predictor of rate of change in femoral neck size and strength during the menopause transition
|
Shieh, A. |
|
|
30 |
12 |
p. 2449-2457 |
artikel |
2 |
A bone resorption marker as predictor of rate of change in femoral neck size and strength during the menopause transition
|
Shieh, A. |
|
|
30 |
12 |
p. 2449-2457 |
artikel |
3 |
A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females
|
Zhang, X. |
|
|
30 |
12 |
p. 2469-2476 |
artikel |
4 |
A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females
|
Zhang, X. |
|
|
30 |
12 |
p. 2469-2476 |
artikel |
5 |
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure
|
Lo, J.C. |
|
|
30 |
12 |
p. 2515-2520 |
artikel |
6 |
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure
|
Lo, J.C. |
|
|
30 |
12 |
p. 2515-2520 |
artikel |
7 |
Bisphosphonate drug holidays
|
Nayak, S. |
|
|
30 |
12 |
p. 2525 |
artikel |
8 |
Bisphosphonates and lower mortality risk: when it sounds to be good to be true …
|
Leslie, W. D. |
|
|
30 |
12 |
p. 2365-2367 |
artikel |
9 |
Bisphosphonates and lower mortality risk: when it sounds to be good to be true …
|
Leslie, W. D. |
|
|
30 |
12 |
p. 2365-2367 |
artikel |
10 |
Bone health in estrogen-free contraception
|
Hadji, P. |
|
|
30 |
12 |
p. 2391-2400 |
artikel |
11 |
Bone health in estrogen-free contraception
|
Hadji, P. |
|
|
30 |
12 |
p. 2391-2400 |
artikel |
12 |
Bone material strength in normoglycemic and hyperglycemic black and white older adults
|
Dawson-Hughes, B. |
|
|
30 |
12 |
p. 2429-2435 |
artikel |
13 |
Bone material strength in normoglycemic and hyperglycemic black and white older adults
|
Dawson-Hughes, B. |
|
|
30 |
12 |
p. 2429-2435 |
artikel |
14 |
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
|
Kendler, D.L. |
|
|
30 |
12 |
p. 2437-2448 |
artikel |
15 |
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
|
Kendler, D.L. |
|
|
30 |
12 |
p. 2437-2448 |
artikel |
16 |
Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas
|
Bouillon, R. |
|
|
30 |
12 |
p. 2521-2522 |
artikel |
17 |
Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas
|
Bouillon, R. |
|
|
30 |
12 |
p. 2521-2522 |
artikel |
18 |
Comorbidity as the dominant predictor of mortality after hip fracture surgeries
|
Cher, Eric Wei Liang |
|
|
30 |
12 |
p. 2477-2483 |
artikel |
19 |
Comorbidity as the dominant predictor of mortality after hip fracture surgeries
|
Cher, Eric Wei Liang |
|
|
30 |
12 |
p. 2477-2483 |
artikel |
20 |
Drug holidays in osteoporosis treatment: mind the gaps!
|
Anagnostis, P. |
|
|
30 |
12 |
p. 2523-2524 |
artikel |
21 |
Drug holidays in osteoporosis treatment: mind the gaps!
|
Anagnostis, P. |
|
|
30 |
12 |
p. 2523-2524 |
artikel |
22 |
Elderly males with or without existing osteoporotic vertebral fracture have much lower future vertebral fracture risk than elderly females: the MrOS (Hong Kong) year-4 follow-up spine radiograph study
|
Wáng, Y.X.J. |
|
|
30 |
12 |
p. 2505-2514 |
artikel |
23 |
Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP—a systematic review
|
Højsager, F.D. |
|
|
30 |
12 |
p. 2381-2389 |
artikel |
24 |
Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict
|
Rothman, M. S. |
|
|
30 |
12 |
p. 2401-2406 |
artikel |
25 |
Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up
|
Png, M.A. |
|
|
30 |
12 |
p. 2417-2428 |
artikel |
26 |
Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up
|
Png, M.A. |
|
|
30 |
12 |
p. 2417-2428 |
artikel |
27 |
Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials
|
Lou, S. |
|
|
30 |
12 |
p. 2369-2380 |
artikel |
28 |
Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men
|
Swanson, C.M. |
|
|
30 |
12 |
p. 2485-2493 |
artikel |
29 |
Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men
|
Swanson, C.M. |
|
|
30 |
12 |
p. 2485-2493 |
artikel |
30 |
Rate of drop in serum calcium as a predictor of hypocalcemic symptoms post total thyroidectomy
|
Saad, R.K. |
|
|
30 |
12 |
p. 2495-2504 |
artikel |
31 |
Rate of drop in serum calcium as a predictor of hypocalcemic symptoms post total thyroidectomy
|
Saad, R.K. |
|
|
30 |
12 |
p. 2495-2504 |
artikel |
32 |
The association between sarcopenia and osteoporotic vertebral compression refractures
|
Wang, W.-F. |
|
|
30 |
12 |
p. 2459-2467 |
artikel |
33 |
The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis
|
Tebé, C. |
|
|
30 |
12 |
p. 2407-2415 |
artikel |
34 |
The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis
|
Tebé, C. |
|
|
30 |
12 |
p. 2407-2415 |
artikel |